MHR
GILD icon

Matthew Hamilton Rosenberg’s Gilead Sciences GILD Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$506K Sell
3,397
-53
-2% -$7.44K 0.09% 114
2026
Q2 		$436K Buy
3,450
+945
+38% +$125K 0.08% 119
2026
Q1 		$349K Sell
2,505
-42
-2% -$5.88K 0.07% 137
2025
Q4 		$313K Buy
2,547
+25
+1% +$3.04K 0.06% 143
2025
Q3 		$280K Hold
2,522
– – 0.06% 159
2025
Q2 		$280K Buy
2,522
+304
+14% +$32.4K 0.07% 154
2025
Q1 		$249K Hold
2,218
– – 0.06% 155
2024
Q4 		$205K Buy
2,218
+50
+2% +$4.5K 0.05% 176
2024
Q3 		$182K Hold
2,168
– – 0.05% 206
2024
Q2 		$149K Hold
2,168
– – 0.04% 226
2024
Q1 		$158K Buy
2,168
+57
+3% +$4.38K 0.05% 227
2023
Q4 		$171K Sell
2,111
-39
-2% -$3.04K 0.05% 209
2023
Q3 		$161K Buy
2,150
+56
+3% +$4.31K 0.05% 205
2023
Q2 		$161K Buy
2,094
+42
+2% +$3.35K 0.05% 210
2023
Q1 		$170K Buy
2,052
+1
+0% +$83 0.05% 212
2022
Q4 		$176K Buy
2,051
+66
+3% +$5.23K 0.06% 200
2022
Q3 		$122K Buy
1,985
+53
+3% +$3.34K 0.05% 247
2022
Q2 		$120K Buy
1,932
+71
+4% +$4.4K 0.05% 263
2022
Q1 		$111K Buy
1,861
+1,225
+193% +$78.3K 0.04% 286
2021
Q4 		$46K Sell
636
-236
-27% -$16.3K 0.02% 426
2021
Q3 		$61K Buy
872
+348
+66% +$24.4K 0.02% 363
2021
Q2 		$36K Sell
524
-61
-10% -$4.07K 0.02% 407
2021
Q1 		$28K Buy
585
+156
+36% +$10.1K 0.02% 404
2020
Q4 		$25K Sell
429
-1,349
-76% -$81.4K 0.02% 403
2020
Q3 		$112K Sell
1,778
-947
-35% -$65.7K 0.08% 181
2020
Q2 		$210K Buy
2,725
+584
+27% +$44.8K 0.17% 77
2020
Q1 		$161K Buy
+2,141
New +$148K 0.16% 69

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Matthew Hamilton Rosenberg's GILD Position: Q3 2026 in Review

Matthew Hamilton Rosenberg reduced its Gilead Sciences (GILD) stake by 1.5% in Q3 2026, selling an estimated $7.44K and leaving 3,397 shares worth $506K. The position accounts for 0.09% of the portfolio, ranked #114.

Matthew Hamilton Rosenberg first reported a position in GILD in Q1 2020 and has held it in 27 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Matthew Hamilton Rosenberg held 3,397 shares of Gilead Sciences worth $506K as of Q3 2026.
  • Matthew Hamilton Rosenberg sold 53 Gilead Sciences shares in Q3 2026, an estimated $7.44K.
  • Gilead Sciences made up 0.09% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #114 holding.
  • Matthew Hamilton Rosenberg first reported a position in Gilead Sciences in Q1 2020 and has held it in 27 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.